| abstract |
Disclosed herein are compositions and methods involving mutant viruses, particularly mutant influenza viruses. The mutant viruses disclosed herein comprise mutant M2 sequences, mutant BM2 sequences, and can be used in immunogenic compositions, eg, as tetravalent vaccines. Also disclosed herein are methods, compositions and cells for propagating virus mutants, and methods, devices and compositions involving vaccination. |